| 2024 | Accurately Controlled Tumor Temperature with Silica-Coated Gold Nanorods for Optimal Immune Checkpoint Blockade Therapy | 김진성; 김광명 | Article |
| 2024 | Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy | 김진성; 이용현; 김광명 | Article |
| 2026 | Cathepsin B-Cleavable Doxorubicin Prodrug Nanoparticles for Eliciting Cancer-Specific Immunogenic Cell Death and Minimizing Systemic Toxicity | 김진성; 유진하; 김광명 | Article |
| 2026 | Effective Degradation of Wild-Type and Mutant EGFR Using Self-Assembling Peptide-Derived PROTAC Nanoparticles (NanoTACs) for Cancer Therapy | 김진성; 김광명 | Article |
| 2026 | Esterase-responsive albumin-binding PROTACmediated BRD4 degradation for cancer immunotherapy | 김진성; 김광명 | Article |
| 2026 | High-dose treatment of cathepsin B-activatable doxorubicin prodrug nanoparticles that induce tumor-specific immunogenic cell death for immunotherapy of melanoma with minimal systemic toxicity | 김진성; 김광명 | Article |
| 2024 | Implantable MicroLED-Mediated Chemo-Photodynamic Combination Therapy for Glioma Treatment | 김진성; 김광명 | Article |
| 2026 | Low-dose radiation generated ROS-activatable doxorubicin prodrug loaded liposome nanoparticles for triple-negative breast cancer treatment | 김진성; 김광명 | Article |
| 2026 | Nanodiscs embedded with μ-opioid receptors as decoy receptors to reverse opioid overdose | 김진성; 김광명; 박태현 | Article |
| 2024 | Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition | 김진성; 김광명 | Review |
| 2023 | Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors | 김진성; 김광명 | Review |
| 2004 | Synthesis and cytotoxicity evaluation of 6,11-dihydro-pyridazo- and 6,11-dihydro-pyrido[2,3-b]phenazine-6,11-diones | 서명은; 김화정; 서은경; 김진성 | Article |
